influenza

Mar 12, 2020

DIAMONDS Project Using New Classification Approach to Develop Rapid Infectious Disease Tests

Premium

Technology partners on the study include BioMérieux and SkylineDx, as well as Imperial College London's biomedical electronics unit.

Mar 05, 2020

Ferris State Team Looking to Expand Scope of Pharmacy-Based Lab Testing

Premium

The researchers are studying use of pharmacy testing to monitor hypertension and cholesterol as well as for detecting and managing various infectious diseases.

Feb 13, 2020

POC Molecular Flu Tests Finding Resistance in Pediatrics Despite High Accuracy

Premium

A recent study established high sensitivity and specificity for three CLIA waived point-of-care molecular flu tests in pediatric samples.

Nov 05, 2019

Lucira Health Receives $11.5M Under Flu Test Development Contract

The firm is developing the test under a contract with the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority.

Oct 30, 2019

Quidel Q3 Revenues Rise 8 Percent, Beat Expectations

The firm saw a 36 percent increase in influenza product sales compared to the third quarter last year.

Oct 29, 2019

Sense Biodetection Raises £12.3M to Develop Instrument-Free MDx Tests

Cambridge, UK-based Sense Biodetection will use the funding to develop a portfolio of instrument-free, point-of-care molecular diagnostic tests.

Oct 22, 2019

BioGx Gets CE-IVD Mark for Respiratory Infection Assay

The test is the latest in a series of CE-IVD-marked assays the company has launched for use on Becton Dickinson's PCR-based BD Max platform.

Oct 11, 2019

EU Researchers Awarded €3M to Develop POC Molecular Tests

Investigators at the Foundation for Research and Technology - Hellas, a Greek research institute, are coordinating the effort.

Oct 09, 2019

Sekisui Diagnostics Receives FDA Clearance, CLIA Waiver for Influenza Test

The company's Acucy Influenza A&B test detects viral nucleoprotein antigens from nasal and nasopharyngeal swabs.

Aug 16, 2019

Inflammatix Preps Immune-Response Sepsis Dx for FDA Clinical Trial, Lays Out Future Test Plans

Premium

Beyond its HostDx Sepsis test, the firm is working on a test to detect and differentiate bacterial from viral infections in patients presenting with fever.

Menu

influenza

DIAMONDS Project Using New Classification Approach to Develop Rapid Infectious Disease Tests

Ferris State Team Looking to Expand Scope of Pharmacy-Based Lab Testing

POC Molecular Flu Tests Finding Resistance in Pediatrics Despite High Accuracy

Lucira Health Receives $11.5M Under Flu Test Development Contract

Quidel Q3 Revenues Rise 8 Percent, Beat Expectations

Sense Biodetection Raises £12.3M to Develop Instrument-Free MDx Tests

BioGx Gets CE-IVD Mark for Respiratory Infection Assay

EU Researchers Awarded €3M to Develop POC Molecular Tests

Sekisui Diagnostics Receives FDA Clearance, CLIA Waiver for Influenza Test

Inflammatix Preps Immune-Response Sepsis Dx for FDA Clinical Trial, Lays Out Future Test Plans

Pages

Breaking News

Thermo Fisher Scientific Prices €1.2B Senior Notes Offering

US Justice Department Sues Anthem for Allegedly Submitting False Diagnosis Data to CMS

Rendu Biotechnology Gets Emergency Approval in China for Coronavirus Detection Kit

Myriad Genetics Seeks Japan Approval for Advanced Pancreatic, Prostate Cancer Companion Diagnostic

White House Wants Hospitals to Report Coronavirus Testing Data

Luminex Receives FDA Emergency Use Authorization for Coronavirus Multiplex Panel

Sponsorships